RxDoctor Payments Data

Loren Spencer, DPM

Podiatrist · Alamogordo, NMNPI 1881852978

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,594 of the $1,915 with a category attached, or 83.2%. 11 manufacturers reported payments, led by Stryker at 25.8% of the total. Reporting peaked in 2024 at $788 and has fallen 50.1% since, to $393 in 2025.

$1,915in general payments, 2019–2025

Across 51 payments — averaging $37.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$494
  • Smith+Nephew$380
  • Johnson & Johnson$321
  • Fusion Orthopedics USA, LLC$285
  • Abbott$150
  • Rattan And Associates$139
  • plus $146 from 5 others

What the payments were for

  • Food & beverage$1,59483%
  • Other$32117%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,915 in reported general payments places this provider in the 60th percentile of 46 podiatrist providers in New Mexico.

See all podiatrist providers in New Mexico

Medicare billing

Part B allowed, 2024
$852,097
Medicare patients
421
Services billed
3,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin30$873
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$551
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim56$355
Doxycycline Monohydrate22$352
Ciclopirox13$350
Gabapentin41$337
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$283
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$267
Doxycycline Hyclate24$262
Terbinafine Hcl29$232
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$230
Ciprofloxacin Hcl12$206
Clindamycin Hcl11$164
Meloxicam22$127
Methylprednisolone13$102

Paid to pharmacies, not to this prescriber.

Other podiatrist in Alamogordo

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →